Health ❯ Medical Treatments

Pharmaceuticals

Weight Loss Drugs Weight Loss Medications Side Effects GLP-1 Agonists Cholesterol-Lowering Drugs Rare Diseases Weight Management Statins GLP-1 Drugs Injectable Medications

Lancet Analysis: Fatty Liver Disease Hits 1.3 Billion Globally, Could Reach 1.8 Billion by 2050

The study ties the rise to poor metabolic health, urging earlier screening.

Birch Pollen Peaks Across Germany With High Exposure

Kendra Wilkinson Plans GLP-1 Weight-Loss Shots to Drop a Few Pounds

Repurposed Epilepsy Drug Cuts Sleep Apnea Events by Up to 47% in Phase II Trial

Ahead of World Glaucoma Day, Experts Urge Annual Eye Exams and Reject Cannabis as Treatment

Prue Leith Ends Mounjaro Trial After No Weight Loss in a Month

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

Michael Schanze Returns to TV After 13 Years, Reveals 93-Kilo Weight Loss

New Review Finds Rapid Weight Return After Stopping GLP-1 Weight-Loss Drugs

Prue Leith Says She’s Done With Weight-Loss Jabs After Ill Effects and No Results

Weight Watchers Rolls Out GLP-1 Support Program and Revamped App With AI Body Scanner

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

Cholesterol Guidance Now: Diet First, Statins Common, Inclisiran Harder to Access

Brain Implants Show Mounjaro Temporarily Quiets Food-Craving Brain Signal

Nikki Reed Calls Out Wellness Industry After Years-Long Mystery Health Ordeal

Sheffield's M102 Slows Motor Neurone Disease in Mice

Amy Schumer Shares Unfiltered Mirror Selfie Showing Slimmer Physique

Anvisa Approves Mounjaro as First Drug Treatment for Obstructive Sleep Apnea in Adults With Obesity

Hertfordshire Mum Drops 10.5 Stone in 16 Months on Mounjaro, Plans to Taper Off

GLP-1 Drugs Tied to Atypical PET-CT Uptake, Raising Misdiagnosis Risk